(A) The barbed end capping and bundling activity of Eps8 requires
an intact H1-to-H2 Linker (Linker mutant) region.
Left: the position of critical, mutated residues of
the H1-to-H2 Linker in the modeled complex
Eps8(648–821):G-actin are indicated by a
star. Middle: the rates of elongation from barbed ends
using spectrin-actin seeds and 2 µM of G-actin (10%
pyrenyl-labeled) in the presence of increasing concentrations
Eps8(648–821)-R706A-F708A-(Eps8-Linker
mutant) (orange line) with respect to
Eps8(648–821)(Eps8-WT) (gray lines) are
shown. Rates are normalized taking as 100% the rate of
elongation from barbed ends measured in the absence of Eps8-WT. Symbols
indicate data; line indicates fitted binding curves for a complex with
1∶1 stoichiometry. The curve is calculated using Equation 1.
The kinetic constants (Kcap) of barbed end inhibition for Eps8-Linker
mutant = 180 nM; Eps8-WT
= 9 nM. Right: the
F-actin bundling ability GST-fused Eps8-WT or Eps8-Linker mutant was
determined by co-sedimentation assays. F-actin (1 µM) was
incubated either alone or in the presence of the indicated
concentrations of GST, as control, or GST-fused WT or mutated
Eps8(648–821). The mix was subjected to
centrifugation at 10,000 g for 30 min. Aliquots of the pellet (P) and
supernatants (S) were analyzed by immunoblotting with the antibodies
indicated on the right. (B) The barbed end capping but not the
bundling activity of Eps8 requires an intact H1 amphipathic
helix. Left: the position of critical,
mutated residues of the H1 in the modeled complex
Eps8(648–821):G-actin are indicated by a
star. Middle: the rates of elongation from barbed ends
using spectrin-actin seeds in the presence of increasing concentrations
of Eps8-WT (gray lines) or
Eps8(648–821)-V689D -L693D
(Eps8-Δcap) (orange line) are shown. The Kcap of the
Eps8-Δcap = 700 nM.
Right: the F-actin bundling ability of the
indicated Eps8-Δcap was determined as described in (A). (C)
The bundling, but not the capping, activity of
Eps8(648–821) is mediated by a Villin-like motif in the
globular, helical domain. Left: the
critical, mutated residues in the Villin-like motif of
Eps8(648–821) are indicated in red, and
their position in the modeled complex
Eps8(648–821):G-actin is indicated by a
star. Middle: the rates of elongation from barbed ends
in the presence of increasing concentrations of
Eps8(648–821)-L757A-K759A
(Eps8-Δbund) (orange line) with respect to Eps8-WT (gray line),
obtained as described in 6A, are shown (Kcap of Eps8-Δbund
= 20 nM).
Right: the F-actin bundling ability of
GST-Eps8-Δbund was determined as in 6A. (D) Actin
capping (middle) and bundling (right) of Eps8(648–821) are
impaired by a mutation in the helix H1 and in the Villin-like motif
(Eps8-ΔcapΔbund), whose position within the
complex Eps8(648–821):G-actin is shown on the
left.